| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |